HKU Develops the World's First Oral Arsenic Trioxide Drug for Leukemia
After more than two decades of research, the LKS Faculty of Medicine, the University of Hong Kong, has developed a fully oral treatment regimen known colloquially as "AAA," consisting of oral arsenic trioxide, all-trans retinoic acid (ATRA) and ascorbic acid. It has shown excellent efficacy…
Continue reading...